Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 26, 2004; DOI: 10.1124/jpet.103.062802
0022-3565/04/3093-1263-1272$20.00
JPET 309:1263-1272, 2004
CARDIOVASCULAR
Glucose-Dependent Enhancement of Spontaneous Phasic Contraction Is Suppressed in Diabetic Mouse Portal Vein: Association with Diacylglycerol-Protein Kinase C Pathway
Koji Nobe,
Hikaru Suzuki,
Yasushi Sakai,
Hiromi Nobe,
Richard J. Paul, and
Kazutaka Momose
Department of Pharmacology, School of Pharmaceutical Sciences (K.N., H.S., H.N., K.M.) and Division of Physiology, Department of Occupational Therapy, School of Nursing and Rehabilitation Sciences (Y.S.), Showa University, Tokyo, Japan; and Department of Molecular and Cellular Physiology (R.J.P.), University of Cincinnati College of Medicine, Cincinnati, Ohio
We investigated portal vein (PV) contractility in diabetes using a mouse model (ob/ob mouse) of spontaneous noninsulin-dependent diabetic mellitus. Spontaneous phasic contraction in control mice (C57Bl) was increased in the presence of the thromboxane A2 analog 9,11-dideoxy-11
, 9
-epoxymethanoprostaglandin F2
(U46619) in a time- and concentration-dependent manner. This response was enhanced under high glucose conditions (22.2 mM). Diacylglycerol (DG) was synthesized from glucose and was not affected by phospholipase C (PLC) inhibition under resting conditions in normal glucose. Inhibition of DG-induced PKC activation with 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo-(2,3-
)pyrrolo(3,4-c)-carbazole (Gö6976), a calcium-dependent protein kinase C (PKC) inhibitor, was only observed under normal glucose conditions. High glucose levels enhanced PLC-independent DG formation followed by an induction of total phosphatidylinositol turnover via calcium-independent PKC activation in C57Bl mice. In ob/ob mice, the high glucose-induced enhancement of PV contraction in response to U46619 was suppressed. These findings suggest that these differences are associated with long-term exposure of tissue to a hyperglycemic state. Under high glucose conditions, DG derived from glucose fell below 50% in C57Bl mice. Moreover, the DG-related calcium-independent PKC was desensitized in ob/ob mice. These results suggest that suppression of the glucose-induced enhancement of PV contraction involves both a decrease in glucose-derived DG formation and reduction of the glucose sensitivity of DG-related PKC.
Received November 10, 2003;
accepted February 24, 2004.
Address correspondence to: Dr. Koji Nobe, Department of Pharmacology, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-0555, Japan. E-mail: kojinobe{at}pharm.showa-u.ac.jp
This article has been cited by other articles:

|
 |

|
 |
 
K. Nobe, T. Yamazaki, N. Tsumita, T. Hashimoto, and K. Honda
Glucose-Dependent Enhancement of Diabetic Bladder Contraction Is Associated with a Rho Kinase-Regulated Protein Kinase C Pathway
J. Pharmacol. Exp. Ther.,
March 1, 2009;
328(3):
940 - 950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nobe, T. Yamazaki, T. Kumai, M. Okazaki, S. Iwai, T. Hashimoto, S. Kobayashi, K. Oguchi, and K. Honda
Alterations of Glucose-Dependent and -Independent Bladder Smooth Muscle Contraction in Spontaneously Hypertensive and Hyperlipidemic Rat
J. Pharmacol. Exp. Ther.,
February 1, 2008;
324(2):
631 - 642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nobe, M. Miyatake, T. Sone, and K. Honda
High-Glucose-Altered Endothelial Cell Function Involves Both Disruption of Cell-to-Cell Connection and Enhancement of Force Development
J. Pharmacol. Exp. Ther.,
August 1, 2006;
318(2):
530 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.